Literature DB >> 19840813

Unique biomechanical interactions between myeloma cells and bone marrow stroma cells.

Yongdong Feng1, Gidon Ofek, Dong Soon Choi, Jianguo Wen, Jerry Hu, Hong Zhao, Youli Zu, Kyriacos A Athanasiou, Chung-Che Chang.   

Abstract

We observed that BMSCs (bone marrow stromal cells) from myeloma patients (myeloma BMSCs) were significantly stiffer than control BMSCs using a cytocompression device. The stiffness of myeloma BMSCs and control BMSCs was further increased upon priming by myeloma cells. Additionally, myeloma cells became stiffer when primed by myeloma BMSCs. The focal adhesion kinase activity of myeloma cells was increased when cells were on stiffer collagen gels and on myeloma BMSCs. This change in myeloma stiffness is associated with increased colony formation of myeloma cells and FAK activation when co-cultured with stiffer myeloma BMSCs or stiffer collagen. Additionally, stem cells of RPMI8226 cells became stiffer after priming by myeloma BMSCs, with concomitant increases of stem cell colony formation. These results suggest the presence of a mechanotransduction loop between myeloma cells and myeloma BMSCs to increase the stiffness of both types of cells via FAK activation. The increase of stiffness may in turn support the growth of myeloma cells and myeloma stem cells. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19840813     DOI: 10.1016/j.pbiomolbio.2009.10.004

Source DB:  PubMed          Journal:  Prog Biophys Mol Biol        ISSN: 0079-6107            Impact factor:   3.667


  7 in total

Review 1.  Multiple myeloma mesenchymal stem cells: characterization, origin, and tumor-promoting effects.

Authors:  Michaela R Reagan; Irene M Ghobrial
Journal:  Clin Cancer Res       Date:  2011-11-07       Impact factor: 12.531

2.  Mechanical segregation and capturing of clonal circulating plasma cells in multiple myeloma using micropillar-integrated microfluidic device.

Authors:  Dongfang Ouyang; Yonghua Li; Wenqi He; Weicong Lin; Lina Hu; Chen Wang; Liangcheng Xu; Jaewon Park; Lidan You
Journal:  Biomicrofluidics       Date:  2019-11-19       Impact factor: 2.800

3.  CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathway.

Authors:  Dan Wu; Xinyi Guo; Jing Su; Ruoying Chen; Dmitriy Berenzon; Martin Guthold; Keith Bonin; Weiling Zhao; Xiaobo Zhou
Journal:  Biochim Biophys Acta       Date:  2014-11-21

4.  SDF-1α stiffens myeloma bone marrow mesenchymal stromal cells through the activation of RhoA-ROCK-Myosin II.

Authors:  Dong Soon Choi; Daniel J Stark; Robert M Raphael; Jianguo Wen; Jing Su; Xiaobo Zhou; Chung-Che Chang; Youli Zu
Journal:  Int J Cancer       Date:  2014-09-02       Impact factor: 7.396

5.  Biomechanics of meniscus cells: regional variation and comparison to articular chondrocytes and ligament cells.

Authors:  Johannah Sanchez-Adams; Kyriacos A Athanasiou
Journal:  Biomech Model Mechanobiol       Date:  2012-01-10

6.  Predicting the impact of combined therapies on myeloma cell growth using a hybrid multi-scale agent-based model.

Authors:  Zhiwei Ji; Jing Su; Dan Wu; Huiming Peng; Weiling Zhao; Brian Nlong Zhao; Xiaobo Zhou
Journal:  Oncotarget       Date:  2017-01-31

7.  Targeting the biophysical properties of the myeloma initiating cell niches: a pharmaceutical synergism analysis using multi-scale agent-based modeling.

Authors:  Jing Su; Le Zhang; Wen Zhang; Dong Song Choi; Jianguo Wen; Beini Jiang; Chung-Che Chang; Xiaobo Zhou
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.